| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 522.413 | 199.575 | - | 123.322 | - | - | - | - | - | - |
| Total Income - EUR | 523.083 | 214.215 | - | 133.669 | - | - | - | - | - | - |
| Total Expenses - EUR | 501.458 | 197.657 | - | 156.584 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 21.625 | 16.557 | - | -22.915 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 12.770 | 16.038 | - | -24.149 | - | - | - | - | - | - |
| Employees | 4 | 3 | - | 2 | - | - | - | - | - | - |
Check the financial reports for the company - Axxobiomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 177.668 | 257.695 | - | 255.691 | - | - | - | - | - | - |
| Current Assets | 413.229 | 173.201 | - | 114.959 | - | - | - | - | - | - |
| Inventories | 32.591 | 5.997 | - | 3.473 | - | - | - | - | - | - |
| Receivables | 96.287 | 96.541 | - | 45.297 | - | - | - | - | - | - |
| Cash | 284.351 | 70.663 | - | 66.190 | - | - | - | - | - | - |
| Shareholders Funds | 446.949 | 248.103 | - | 197.684 | - | - | - | - | - | - |
| Social Capital | 45 | 45 | - | 43 | - | - | - | - | - | - |
| Debts | 143.948 | 185.730 | - | 177.825 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Axxobiomed Srl